Savvy Trades and Investments

[researcher59]

SBH +2.43 to 17.11, after posting decent earnings and long term guidance - I sold most of my position this morning and hope to buy back lower.

 
 briefing - 
  
 Sally Beauty beats by $0.07, beats on revs; guides Q1 EPS below consensus, revs below consensus; guides FY26 EPS in-line, revs in-line (14.68 ) : 
 Reports Q4 (Sep) earnings of $0.55 per share, excluding non-recurring items, $0.07 better than the FactSet Consensus of $0.48; revenues rose 1.3% year/year to $947.1 mln vs the $933.24 mln FactSet Consensus. 
 Co issues downside guidance for Q1, sees EPS of $0.43-0.47, excluding non-recurring items, vs. $0.50 FactSet Consensus; sees Q1 revs of $935-945 mln vs. $946.69 mln FactSet Consensus. 
 Co issues in-line guidance for FY26, sees EPS of $2.00-2.10, excluding non-recurring items, vs. $2.02 FactSet Consensus; sees FY26 revs of $3.71-3.77 bln vs. $3.73 bln FactSet Consensus. 
 Long-Term Outlook - The Company is introducing financial targets to reflect its three-year planning horizon ending with fiscal 2028, as follows: 
 Consolidated net sales growth in the range of 1% to 3%, annually; 
 Adjusted Operating Earnings growth in the range of 3% to 5%, annually; 
 Adjusted Diluted EPS growth of 10%+, annually; including approximately 50% of Free Cash Flow deployed towards share repurchases; 
 Capital expenditures in the range of $90 million to $120 million; and 
 Free Cash Flow of approximately $200 million, annually.